Artificial Intelligence

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

A Charlotte dentist’s late-night parenting struggle sparks a patented invention, disrupting a beloved childhood tradition and making her a national innovator.

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.

An expanded partnership aims to move businesses from AI experimentation to autonomous operations, tackling the critical 'last-mile problem' of value realization.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

With new CEO Stan Lequin and private equity backing, Fidus Systems is pivoting to infuse AI into embedded design, signaling a new era of growth and M&A.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

Digital health leader Bunny Ellerin joins Aegis Ventures as Chief Ecosystem Officer, a strategic move to fuel AI-native innovation through network power.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.

New preclinical data for ATNM-400 and Actimab-A shows promise for treating resistant solid tumors and AML, highlighting a new frontier in cancer therapy.

A key summit will dissect Vietnam's plan to navigate US tariffs and Mideast conflict while pursuing its ambitious goal of becoming a high-income nation.

Despite risks from Mideast conflict, the ASEAN+3 region's 4% growth forecast is backed by deep internal trade and a shift away from global dependence.

Crypto exchange Backpack appoints ex-Coinbase tech lead Nathan Smith as COO, signaling a major push for operational scale amid aggressive global expansion.

A new grant from entrepreneur Andrew Hillman seeks global talent to solve biotech's biggest challenges. Who is the man behind this ambitious mission?

A win at the prestigious NMHC Young Guns competition signals a new era for multifamily investment, where AI and data analytics are the keys to value.

Finnish defense firm Sensofusion buys aircraft maker Atol Aviation, shifting counter-drone warfare from the ground to the sky in a major strategic leap.